Cameron G. Binnie - Concepedia

Author

Cameron G. Binnie

University of North Carolina at Chapel Hill

Also Known As

C G Binnie, C. G. Binnie, Cameron Binnie, Cameron G Binnie, Cameron G. Binnie, Gorkun, O. V.

Publications

500

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill

About

Cameron G. Binnie is an author at University of North Carolina at Chapel Hill specializing in medicine, natural sciences, and molecular diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	159
2	Natural Sciences	3	3	74
3	Biochemistry	2	2	53
4	Public Health	1	1	15
5	Biostatistics	1	1	15

Cameron G. Binnie

Publications

460

Citations

H-Index

Page 1

	Year	Citations
Distribution of 13 truncating mutations in the neurofibromatosis 1 gene Ruth A. Heim, Lauren Kam-Morgan, Cameron G. Binnie, Human Molecular Genetics	1995	184
In vitro transcription/translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer Michael C. Luce, Giancarlo Marra, Dharam P. Chauhan, Gastroenterology Hmsh2 MutationsCancer PathologySomatic VariantMedicinePathology	1995	70
Characterization of purified recombinant fibrinogen: partial phosphorylation of fibrinopeptide A Cameron G. Binnie, Joann M. Hettasch, E. Strickland, Biochemistry	1993	61
Recombinant Fibrinogen Studies Reveal That Thrombin Specificity Dictates Order of Fibrinopeptide Release Jennifer L. Mullin, Oleg V. Gorkun, Cameron G. Binnie, Journal of Biological Chemistry	2000	43
A synthetic analog of fibrinogen alpha 27-50 is an inhibitor of thrombin. Cameron G. Binnie, Susan T. Lord PubMed Synthetic Peptide Aakdsdwpfas-dedwnykapsgarImmunologyPharmacotherapyThrombosisBioanalysis	1991	28
A Synthetic Analog of Fibrinogen α27–50 Is an Inhibitor of Thrombin Cameron G. Binnie, Susan T. Lord Thrombosis and Haemostasis Peptide ScienceAnalytical UltracentrifugationThrombosisMolecular PharmacologyBioanalysis	1991	25
Purification and characterization of recombinant human fibrinogen. Susan T. Lord, Cameron G. Binnie, Joann M. Hettasch, PubMed Plasma FibrinogenImmunologyBiofabricationSame Expression VectorCellular Physiology	1993	21
A case-based evaluation of SRD5A1, SRD5A2, AR, and ADRA1A as candidate genes for severity of BPH Michael Klotsman, Clarice R. Weinberg, Kimberly H. Davis, The Pharmacogenomics Journal Candidate GenesMedicineGeneticsGenetic EpidemiologyHuman Polymorphism	2004	15
Inhibition of thrombin by synthetic hirudin peptides Cameron G. Binnie, Bruce W. Erickson, Jan Hermans FEBS Letters	1990	13

Page 1